Wilson Sonsini Goodrich & Rosati represented Saniona in the transaction. Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, announced a partnership with Acadia Pharmaceuticals (Acadia) for the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Vambe in the transaction. Santiago, Chile-based Vambe, a conversational AI start-up, announced raising a $3.85 million Seed round. The round...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Lightsynq on the transaction. Lightsynq Technologies, a start-up developing quantum interconnect technology solutions for commercial use, emerged from stealth and...
You must be a Standard 1 Year member to access this content.
McCarter & English announced the addition of former DOJ antitrust attorney Robin Crauthers. Crauthers brings to the firm more than a decade of antitrust experience in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenstorrent on the transaction. Tenstorrent, a next-generation computing company that builds computers for AI, announced the closing of over $693...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented 9fin; Osborne Clarke advised Highland Europe. 9fin, the AI-powered analytics platform for debt capital markets, announced it has raised $50...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented 6 Dimensions and VFLO in this transaction. Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Forte Biosciences, while Paul Hastings advised TD Cowen in the transaction. Biopharmaceutical company, Forte Biosciences, announced an oversubscribed $53 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Doron Therapeutics on the transaction. Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, announced it has raised...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised GI Windows Surgical on the transaction. Massachusetts-based GI Windows Surgical, a clinical-stage medical device company dedicated to developing the first...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Epic Cleantec in the transaction. Epic Cleantec (Epic), a leader in water reuse technology for the built environment, announced the...
You must be a Standard 1 Year member to access this content.
